I wouldn't be surprised if PAR do not release the 12 month data and instead just release an update saying they'll be taking all data to the FDA. Technically, PAR do not need to release the results of low level secondary endpoints. Many companies withhold the results and analysis of some of their secondary endpoints and only release top-line data and key secondary endpoints. The 12 month data represent neither of these.
I wouldn't be surprised if PAR do not release the 12 month data...
-
- There are more pages in this discussion • 628 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
0.015(6.52%) |
Mkt cap ! $85.7M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 24.5¢ | 23.0¢ | $116.0K | 491.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 33682 | 3 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| PAR (ASX) Chart |